【作者】 芦柏震； 毛伟敏； 王晓稼； 周俐斐； 周佳佳；

【机构】 浙江省肿瘤医院；

【摘要】 目的初步探讨清肺合剂对中青年及老年原发性肺癌患者的临床疗效及生存状况。方法选择2003年1月~2008年12月间收治的肺癌病人中,连续服用清肺合剂3年以上的原发性肺癌患者120例,分别入组中青年组和老年组,分析其临床特点构成和生存状况。结果120例肺癌患者中,64.17%的中晚期肺癌患者的生存率达3年以上,高于同类文献报道。中青年组和老年组的临床构成比中吸烟、病理类型、治疗方式、TNM分期等因素具有统计学意义。清肺合剂对青年人肺癌和非青年人肺癌的咳嗽、咳痰、痰血、胸痛等有效缓解率达70%以上,对两组人群的临床症状改善情况无明显差异。结论清肺合剂在改善患者的临床症状,提高生活质量等方面已得到证实,但对于肺癌手术后及放、化疗后的长期预防治疗及是否有延长生存期的作用,还有待进一步证实。更多还原

【Abstract】 Objective:To observe the clinical effect and survival state of youth and elderly primarily lung cancer patients treated with Qingfei Mixture.Methods:120 patients with diagnosis of primarily lung cancer and treated with Qingfei Mixture between January 2003 and December2008 were selected and assigned to youth group and elderly group.These patients’ clinical characteristics and survival state were analyzed.Results:64.17%of 120 patients exceed 3-year survival time,which was higher than congenial literature.Cigarette,pathological type,treatment,TNM stage in the youth group had statistical significance differences compared with the elder group.Qingfei Mixture can improve clinical symptoms of primarily lung cancer,and the rate was more than 70%.Conclusion:It was proved that Qingfei Mixture can improve clinical symptom,enhance quality of life,but the effects of prevention,cure and extension the survival period on lung cancer patients after operation,radiotherapy or chemotherapy are need to be further proved.更多还原